Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2017

Feb 1, 2017

29745_dirs_2017-01-31_db3300b8-93d5-4226-9178-966fab7de76d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-01-27

Reporting Person: Walsh Fionnuala M (SVP, Global Quality)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-01-27 Common Stock A 9081 $75.38 Acquired 64699 Direct
2017-01-27 Common Stock A 8539 $75.38 Acquired 40190 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-01-27 Restricted Stock Unit $ A 9596 Acquired 2018-02-01 Common Stock (9596.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1041 Indirect
Common Stock 1127 Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.